Results
1 -
7 of
7Bagal Sharan K., Brown Alan D., Cox Peter J., Omoto Kiyoyuki, Owen Robert M., Pryde David C., Sidders Benjamin, Skerratt Sarah E., Stevens Edward B., Storer R. Ian, Swain Nigel A..
Ion Channels as Therapeutic Targets: A Drug Discovery Perspective, Journal of Medicinal Chemistry, 2013 Senicapoc: Repurposing a Drug to Target Microglia KCa3.1 in Stroke, Neurochemical Research Intermediate conductance, Ca2+-activated K+ channels: a novel target for chronic renal diseases, Frontiers in Biology Human lung myofibroblast TGF??1-dependent Smad2/3 signalling is Ca2+-dependent and regulated by KCa3.1 K+ channels, Fibrogenesis & Tissue Repair Increased constitutive ??SMA and Smad2/3 expression in idiopathic pulmonary fibrosis myofibroblasts is KCa3.1-dependent, Respiratory Research Pharma compounds at the crossroads, Science-Business eXchange Potassium channel KCa3.1 (KCNN4), Science-Business eXchange